Copyright Reports & Markets. All rights reserved.

Global Carbapenem API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Carbapenem API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Ertapenem API
    • 1.3.3 Imipenem API
    • 1.3.4 Meropenem API
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Carbapenem API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Intravenous Injection
    • 1.4.3 Intramuscular Injection
  • 1.5 Global Carbapenem API Market Size & Forecast
    • 1.5.1 Global Carbapenem API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Carbapenem API Sales Quantity (2020-2031)
    • 1.5.3 Global Carbapenem API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 ACS Dobfar
    • 2.1.1 ACS Dobfar Details
    • 2.1.2 ACS Dobfar Major Business
    • 2.1.3 ACS Dobfar Carbapenem API Product and Services
    • 2.1.4 ACS Dobfar Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 ACS Dobfar Recent Developments/Updates
  • 2.2 Savior Lifetec Corporation
    • 2.2.1 Savior Lifetec Corporation Details
    • 2.2.2 Savior Lifetec Corporation Major Business
    • 2.2.3 Savior Lifetec Corporation Carbapenem API Product and Services
    • 2.2.4 Savior Lifetec Corporation Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Savior Lifetec Corporation Recent Developments/Updates
  • 2.3 Sumitomo Chemical Company
    • 2.3.1 Sumitomo Chemical Company Details
    • 2.3.2 Sumitomo Chemical Company Major Business
    • 2.3.3 Sumitomo Chemical Company Carbapenem API Product and Services
    • 2.3.4 Sumitomo Chemical Company Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sumitomo Chemical Company Recent Developments/Updates
  • 2.4 Shenzhen Haibin Pharmaceutical
    • 2.4.1 Shenzhen Haibin Pharmaceutical Details
    • 2.4.2 Shenzhen Haibin Pharmaceutical Major Business
    • 2.4.3 Shenzhen Haibin Pharmaceutical Carbapenem API Product and Services
    • 2.4.4 Shenzhen Haibin Pharmaceutical Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
  • 2.5 Zhuhai United Laboratories
    • 2.5.1 Zhuhai United Laboratories Details
    • 2.5.2 Zhuhai United Laboratories Major Business
    • 2.5.3 Zhuhai United Laboratories Carbapenem API Product and Services
    • 2.5.4 Zhuhai United Laboratories Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Zhuhai United Laboratories Recent Developments/Updates
  • 2.6 Zhejiang Hisun Pharmaceutical
    • 2.6.1 Zhejiang Hisun Pharmaceutical Details
    • 2.6.2 Zhejiang Hisun Pharmaceutical Major Business
    • 2.6.3 Zhejiang Hisun Pharmaceutical Carbapenem API Product and Services
    • 2.6.4 Zhejiang Hisun Pharmaceutical Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
  • 2.7 Zhejiang Jiuzhou Pharmaceutical
    • 2.7.1 Zhejiang Jiuzhou Pharmaceutical Details
    • 2.7.2 Zhejiang Jiuzhou Pharmaceutical Major Business
    • 2.7.3 Zhejiang Jiuzhou Pharmaceutical Carbapenem API Product and Services
    • 2.7.4 Zhejiang Jiuzhou Pharmaceutical Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
  • 2.8 Sun Pharma
    • 2.8.1 Sun Pharma Details
    • 2.8.2 Sun Pharma Major Business
    • 2.8.3 Sun Pharma Carbapenem API Product and Services
    • 2.8.4 Sun Pharma Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Sun Pharma Recent Developments/Updates
  • 2.9 Kopran
    • 2.9.1 Kopran Details
    • 2.9.2 Kopran Major Business
    • 2.9.3 Kopran Carbapenem API Product and Services
    • 2.9.4 Kopran Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Kopran Recent Developments/Updates
  • 2.10 Hainan Haiyao
    • 2.10.1 Hainan Haiyao Details
    • 2.10.2 Hainan Haiyao Major Business
    • 2.10.3 Hainan Haiyao Carbapenem API Product and Services
    • 2.10.4 Hainan Haiyao Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Hainan Haiyao Recent Developments/Updates
  • 2.11 Zhejiang Hisoar
    • 2.11.1 Zhejiang Hisoar Details
    • 2.11.2 Zhejiang Hisoar Major Business
    • 2.11.3 Zhejiang Hisoar Carbapenem API Product and Services
    • 2.11.4 Zhejiang Hisoar Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Zhejiang Hisoar Recent Developments/Updates
  • 2.12 Kaliberr Labs
    • 2.12.1 Kaliberr Labs Details
    • 2.12.2 Kaliberr Labs Major Business
    • 2.12.3 Kaliberr Labs Carbapenem API Product and Services
    • 2.12.4 Kaliberr Labs Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Kaliberr Labs Recent Developments/Updates
  • 2.13 Jeil Pharmaceutical
    • 2.13.1 Jeil Pharmaceutical Details
    • 2.13.2 Jeil Pharmaceutical Major Business
    • 2.13.3 Jeil Pharmaceutical Carbapenem API Product and Services
    • 2.13.4 Jeil Pharmaceutical Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Jeil Pharmaceutical Recent Developments/Updates
  • 2.14 Qilu Pharmaceutical
    • 2.14.1 Qilu Pharmaceutical Details
    • 2.14.2 Qilu Pharmaceutical Major Business
    • 2.14.3 Qilu Pharmaceutical Carbapenem API Product and Services
    • 2.14.4 Qilu Pharmaceutical Carbapenem API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Qilu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Carbapenem API by Manufacturer

  • 3.1 Global Carbapenem API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Carbapenem API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Carbapenem API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Carbapenem API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Carbapenem API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Carbapenem API Manufacturer Market Share in 2024
  • 3.5 Carbapenem API Market: Overall Company Footprint Analysis
    • 3.5.1 Carbapenem API Market: Region Footprint
    • 3.5.2 Carbapenem API Market: Company Product Type Footprint
    • 3.5.3 Carbapenem API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Carbapenem API Market Size by Region
    • 4.1.1 Global Carbapenem API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Carbapenem API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Carbapenem API Average Price by Region (2020-2031)
  • 4.2 North America Carbapenem API Consumption Value (2020-2031)
  • 4.3 Europe Carbapenem API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Carbapenem API Consumption Value (2020-2031)
  • 4.5 South America Carbapenem API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Carbapenem API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Carbapenem API Sales Quantity by Type (2020-2031)
  • 5.2 Global Carbapenem API Consumption Value by Type (2020-2031)
  • 5.3 Global Carbapenem API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Carbapenem API Sales Quantity by Application (2020-2031)
  • 6.2 Global Carbapenem API Consumption Value by Application (2020-2031)
  • 6.3 Global Carbapenem API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Carbapenem API Sales Quantity by Type (2020-2031)
  • 7.2 North America Carbapenem API Sales Quantity by Application (2020-2031)
  • 7.3 North America Carbapenem API Market Size by Country
    • 7.3.1 North America Carbapenem API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Carbapenem API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Carbapenem API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Carbapenem API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Carbapenem API Market Size by Country
    • 8.3.1 Europe Carbapenem API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Carbapenem API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Carbapenem API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Carbapenem API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Carbapenem API Market Size by Region
    • 9.3.1 Asia-Pacific Carbapenem API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Carbapenem API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Carbapenem API Sales Quantity by Type (2020-2031)
  • 10.2 South America Carbapenem API Sales Quantity by Application (2020-2031)
  • 10.3 South America Carbapenem API Market Size by Country
    • 10.3.1 South America Carbapenem API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Carbapenem API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Carbapenem API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Carbapenem API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Carbapenem API Market Size by Country
    • 11.3.1 Middle East & Africa Carbapenem API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Carbapenem API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Carbapenem API Market Drivers
  • 12.2 Carbapenem API Market Restraints
  • 12.3 Carbapenem API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Carbapenem API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Carbapenem API
  • 13.3 Carbapenem API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Carbapenem API Typical Distributors
  • 14.3 Carbapenem API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Carbapenem API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Carbapenem API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Carbapenem API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Carbapenem API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Carbapenem API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Carbapenem API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Carbapenem API
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Carbapenem API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ACS Dobfar, Savior Lifetec Corporation, Sumitomo Chemical Company, Shenzhen Haibin Pharmaceutical, Zhuhai United Laboratories, Zhejiang Hisun Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Sun Pharma, Kopran, Hainan Haiyao, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Carbapenem API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Ertapenem API
    Imipenem API
    Meropenem API
    Others
    Market segment by Application
    Intravenous Injection
    Intramuscular Injection
    Major players covered
    ACS Dobfar
    Savior Lifetec Corporation
    Sumitomo Chemical Company
    Shenzhen Haibin Pharmaceutical
    Zhuhai United Laboratories
    Zhejiang Hisun Pharmaceutical
    Zhejiang Jiuzhou Pharmaceutical
    Sun Pharma
    Kopran
    Hainan Haiyao
    Zhejiang Hisoar
    Kaliberr Labs
    Jeil Pharmaceutical
    Qilu Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Carbapenem API product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Carbapenem API, with price, sales quantity, revenue, and global market share of Carbapenem API from 2020 to 2025.
    Chapter 3, the Carbapenem API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Carbapenem API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Carbapenem API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Carbapenem API.
    Chapter 14 and 15, to describe Carbapenem API sales channel, distributors, customers, research findings and conclusion.

    Buy now